BAX - Baxter International Inc.

NYSE - NYSE Delayed Price. Currency in USD
80.56
+1.71 (+2.17%)
At close: 4:00PM EDT

80.56 0.00 (0.00%)
After hours: 4:27PM EDT

Stock chart is not supported by your current browser
Previous Close78.85
Open79.61
Bid80.36 x 800
Ask81.07 x 1300
Day's Range79.13 - 80.63
52 Week Range61.05 - 82.25
Volume3,323,014
Avg. Volume2,641,060
Market Cap41.099B
Beta (3Y Monthly)1.07
PE Ratio (TTM)27.48
EPS (TTM)2.93
Earnings DateJul 25, 2019
Forward Dividend & Yield0.88 (1.20%)
Ex-Dividend Date2019-06-06
1y Target Est82.93
Trade prices are not sourced from all markets
  • Business Wireyesterday

    Baxter Highlights Renal Care Data about Patients’ Health-Related, Quality of Life Outcomes at the 56th ERA-EDTA Congress

    Baxter International Inc. (BAX), a global innovator in renal care, showcased 19 data presentations on therapy options at the 56th ERA-EDTA Congress, Budapest, Hungary, June 13-16. The presentations spanned the renal care continuum, from chronic kidney disease (CKD) management to peritoneal dialysis (PD) and hemodialysis (HD).

  • Here's Why You Should Hold Baxter International (BAX) for Now
    Zacksyesterday

    Here's Why You Should Hold Baxter International (BAX) for Now

    Baxter (BAX) expects its bottom line to rise in the second quarter of 2019, courtesy to Renal Care and Clinical Nutrition businesses.

  • Baxter (BAX) Moves to Buy: Rationale Behind the Upgrade
    Zacks4 days ago

    Baxter (BAX) Moves to Buy: Rationale Behind the Upgrade

    Baxter (BAX) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

  • Business Wire4 days ago

    Baxter Leads Hemodialysis Research Consortium for German Federal Ministry of Education and Research

    Baxter International Inc. (BAX), a global innovator in renal care, today announced receipt of a major research and development (R&D) grant from the German Federal Ministry of Education and Research (BMBF)’s “From Material to Innovation” program to lead a consortium investigating an anticoagulation-free hemodialysis (HD) option for end-stage renal disease (ESRD) patients. The grant provides €1.5 million in funding over three years to Baxter’s research team in Hechingen, Germany, and the consortium partners to find a solution that will improve health-related, quality-of-life outcomes for the millions of patients receiving HD therapy globally.

  • Here’s What Hedge Funds Think About Baxter International Inc. (BAX)
    Insider Monkey5 days ago

    Here’s What Hedge Funds Think About Baxter International Inc. (BAX)

    Concerns over rising interest rates and expected further rate increases have hit several stocks hard during the fourth quarter. Trends reversed 180 degrees during the first quarter amid Powell's pivot and optimistic expectations towards a trade deal with China. Hedge funds and institutional investors tracked by Insider Monkey usually invest a disproportionate amount of their […]

  • Markit5 days ago

    See what the IHS Markit Score report has to say about Baxter International Inc.

    Baxter International Inc NYSE:BAXView full report here! Summary * Perception of the company's creditworthiness is neutral * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for BAX with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting BAX. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding BAX totaled $79.78 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swap | NeutralThe current level displays a neutral indicator. BAX credit default swap spreads are near their highest levels of the last 3 years, which indicates the market's more negative perception of the company's credit worthiness.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • QDEL vs. BAX: Which Stock Is the Better Value Option?
    Zacks6 days ago

    QDEL vs. BAX: Which Stock Is the Better Value Option?

    QDEL vs. BAX: Which Stock Is the Better Value Option?

  • Baxter's (BAX) New Sharesource 2.0 to Improve PD Treatment
    Zacks6 days ago

    Baxter's (BAX) New Sharesource 2.0 to Improve PD Treatment

    Baxter's (BAX) Sharesource 2.0 provides a more comprehensive patient treatment summary to enable faster clinical insights.

  • Business Wire7 days ago

    Baxter to Host Second Quarter 2019 Financial Results Conference Call for Investors

    Baxter International Inc. (BAX), a leading global medical products company, will host a conference call to discuss its second quarter 2019 financial results on Thursday, July 25, 2019, at 7:30 a.m. Central Time. The Conference ID is 2089733.

  • Baxter Launches Sharesource 2.0 Telehealth Platform to Support Greater Clinical Insights and Personalized Peritoneal Dialysis Care
    Business Wire7 days ago

    Baxter Launches Sharesource 2.0 Telehealth Platform to Support Greater Clinical Insights and Personalized Peritoneal Dialysis Care

    DEERFIELD, Ill.-- -- Enhancements designed to give healthcare providers access to more comprehensive treatment data and improve clinic workflow New study further supports value of remote patient management technology to personalize dialysis treatments, reduce alarms and in-person visits, while saving clinicians and patients significant time Baxter International Inc. , a global innovator in renal care, ...

  • What Investors Should Know About Baxter International Inc.'s (NYSE:BAX) Financial Strength
    Simply Wall St.7 days ago

    What Investors Should Know About Baxter International Inc.'s (NYSE:BAX) Financial Strength

    Baxter International Inc. (NYSE:BAX), a large-cap worth US$40b, comes to mind for investors seeking a strong and...

  • Business Wire14 days ago

    The Baxter International Foundation Commits $2 Million+ to Operation Smile Care Centers in India

    The Baxter International Foundation, the philanthropic arm of Baxter International Inc. (BAX), announced today a $2.2 million grant to Operation Smile, one of the world’s largest volunteer-based surgical nonprofit organizations, to deliver free surgical and multidisciplinary care to underserved communities in India. During the next three years, the grant will support Operation Smile’s year-round care centers in Mumbai, Srinagar and Bangalore—operated in partnership with the Inga Health Foundation—along with a new care center in Durgapur, West Bengal.

  • Business Wire21 days ago

    Baxter Announces New Research on 3-in-1 Oxiris Set for CRRT and Sepsis Management

    Baxter International Inc. (BAX), a global leader in acute care therapies, announced today that the peer-reviewed journal Blood Purification published a supplemental issue sponsored by Baxter that features real-world clinical experience with the company’s Oxiris filter, which can be used simultaneously in continuous renal replacement therapy (CRRT) and in the removal of cytokines and endotoxin to aide in the management of acute kidney injury (AKI) patients with sepsis. The studies, which are being highlighted at the 37th Vicenza Course on AKI and CRRT in Italy this week, add to the body of scientific knowledge around the use of extracorporeal (outside the body) blood purification (EBP) to address critical conditions.

  • Baxter (BAX) Down 1.5% Since Last Earnings Report: Can It Rebound?
    Zacks24 days ago

    Baxter (BAX) Down 1.5% Since Last Earnings Report: Can It Rebound?

    Baxter (BAX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Top Research Reports for Cigna, EOG Resources & Northrop Grumman
    Zackslast month

    Top Research Reports for Cigna, EOG Resources & Northrop Grumman

    Top Research Reports for Cigna, EOG Resources & Northrop Grumman

  • Barrons.comlast month

    3 Stocks That Hiked Their Dividends This Week

    Synchrony Financial announced before the opening bell Thursday that it will increase its quarterly dividend by a penny, following dividend increases by Phillips 66 and Baxter International.

  • Business Wirelast month

    Baxter to Conduct Fixed Income Investor Presentations

    Baxter International Inc. (BAX), a leading global medical products company, today announced that representatives of the company will conduct a series of Fixed Income Investor Presentations on Thursday, May 9, 2019.

  • Baxter International Inc. (NYSE:BAX) Delivered A Better ROE Than Its Industry
    Simply Wall St.last month

    Baxter International Inc. (NYSE:BAX) Delivered A Better ROE Than Its Industry

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Many investors are still learning about the various metrics that can be useful when analysing a stock...

  • BAX vs. CLPBY: Which Stock Is the Better Value Option?
    Zackslast month

    BAX vs. CLPBY: Which Stock Is the Better Value Option?

    BAX vs. CLPBY: Which Stock Is the Better Value Option?

  • Business Wirelast month

    Baxter Named a “Best Company for Multicultural Women” by Working Mother

    Baxter International Inc. (BAX), a leading global medical products company, announced today that it has been named a 2019 Best Company for Multicultural Women by Working Mother magazine. This recognition is a result of the company’s sustained focus on supporting and advancing multicultural women at all levels of the organization globally.

  • Business Wirelast month

    Baxter Increases Dividend and Declares Quarterly Dividend

    Baxter International Inc. , a leading global medical products company, today announced an increase in the company’s quarterly cash dividend, to a rate of $0.22 per share of common stock.

  • Business Wire2 months ago

    Baxter to Present at the UBS Global Healthcare Conference

    Baxter International Inc. (BAX), a leading global medical products company, will present at the UBS Global Healthcare Conference on Monday, May 20, 2019 in New York. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 1:00 p.m. Eastern Time.

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of BAX earnings conference call or presentation 25-Apr-19 12:30pm GMT

    Q1 2019 Baxter International Inc Earnings Call